Close

Mindray Medical International (MR) Tops Q4 EPS by 3c, Offers FY12 Guidance

February 27, 2012 5:04 PM EST
Mindray Medical International (NYSE: MR) reported Q4 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $264.1 million versus the consensus estimate of $249.17 million.

The company expects its full year 2012 net revenues to grow at least 18% over its full year 2011 net revenues. The company also expects its full year 2012 non-GAAP net income to grow at least 13% over its non-GAAP net income for full year 2011.

For earnings history and earnings-related data on Mindray Medical International (MR) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings